Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing ...
By Pierre Bertrand Roche said that the U.S. Food and Drug Administration has designated its Inavolisib breast cancer treatment as a breakthrough therapy.
The US Food and Drug Administration (FDA) has granted Roche a breakthrough therapy designation for its breast cancer therapy ...
Roche RHHBY obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult ...
(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) and its U.S. Unit Genentech announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for ...
J&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority Review tags to Sanofi's (SNY ...
Moderna's individualized neoantigen therapy, mRNA-4157, has produced compelling results in stage III/IV melanoma patients.
AI tools have impressive potential in personalizing treatments, but doctors are concerned about bias, generalizability, and ...
Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.
LLY has been on a tear, with their stock price hitting all-time highs recently and closing the week at around $820. However, ...